Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan

• Published in: Expert review of vaccines Vol. 23; no. 1; pp. 546 - 560
• Main Authors: Nakamura, Shigeki, Mikami, Masashi, Hayamizu, Tomoyuki, Yonemoto, Naohiro, Moyon, Camille, Gouldson, Mark, Crossan, Catriona, Vietri, Jeffrey, Kamei, Kazumasa
• Format: Journal Article
• Language: English
• Published: England Taylor & Francis Group 31.12.2024
• Subjects: Cost-effectiveness; invasive pneumococcal disease; Japan; PCV20; pneumococcal disease; vaccination; invasive pneumococcal disease; Cost-effectiveness; Japan; PCV20; pneumococcal disease; vaccination

The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is used in the Japanese National Immunization Program for older adults and adults with increased risk for pneumococcal disease, however, disease incidence and associated burden remain high. We evaluated the cost-effectiveness of pneumococcal...